Haleon HLN
NYSE HLN
$9.87 -0.01 (-0.10%)
At close: Aug 20, 2026 · 4:00 PM EDT

Haleon (HLN) Short-Term Debt repayments (2022)

Haleon's (HLN) quarterly Short-Term Debt repayments came in at -$13.5 million in Q3 2022.

Haleon (HLN) Short-Term Debt repayments (2022) Analysis & Trends

Haleon (HLN) has 1 years of Short-Term Debt repayments data on file, last reported at -$13.5 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Alkermes 8.02 Bn 7.37 Bn 397.90 Mn -

Historic Data

Download Data
DateValue
Sep 20, 2022 -13.54 Mn
Sep 20, 2022 -13.54 Mn